APP, a Fresenius Kabi Company, is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products. Our primary focus is the anesthetic/analgesic, anti-infective, critical care and oncology markets.

Our products are used in hospitals, long-term care facilities, alternate care sites and clinics throughout North America, and are manufactured in a comprehensive range of dosage formulations. APP makes healthcare more affordable for millions of patients with critical and chronic illness in North America.